Marc Schegerin - Oct 13, 2021 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Signature
/s/ Robert Farrell as attorney-in-fact for Marc Schegerin
Stock symbol
MORF
Transactions as of
Oct 13, 2021
Transactions value $
-$1,327,281
Form type
4
Date filed
10/15/2021, 07:00 PM
Previous filing
Jun 17, 2021
Next filing
Oct 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise $29.5K +1.96K +30.1% $15.00 8.49K Oct 13, 2021 Direct F1
transaction MORF Common Stock Sale -$118K -1.96K -23.13% $60.00 6.53K Oct 13, 2021 Direct F2, F3
transaction MORF Common Stock Options Exercise $363K +24.2K +370.58% $15.00 30.7K Oct 14, 2021 Direct
transaction MORF Common Stock Sale -$1.45M -24.2K -78.75% $60.02 6.53K Oct 14, 2021 Direct F2, F4
transaction MORF Common Stock Options Exercise $50.1K +3.34K +51.15% $15.00 9.86K Oct 15, 2021 Direct
transaction MORF Common Stock Sale -$200K -3.34K -33.84% $60.00 6.53K Oct 15, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Disposed to Issuer $0 -1.96K -0.87% $0.00 224K Oct 13, 2021 Common Stock 1.96K $15.00 Direct F5
transaction MORF Stock Option (right to buy Common Stock) Disposed to Issuer $0 -24.2K -10.81% $0.00 199K Oct 14, 2021 Common Stock 24.2K $15.00 Direct F5
transaction MORF Stock Option (right to buy Common Stock) Disposed to Issuer $0 -3.34K -1.67% $0.00 196K Oct 15, 2021 Common Stock 3.34K $15.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 147 shares of Common Stock acquired under the Issuer's employee stock purchase plan on August 31, 2021.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.085 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.245 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The option vests as to 25% of the total shares on April 6, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on April 6, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date.